Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 752 All time
- Disclosed funding
- $25.4B 616 disclosed amounts
- Median round
- $15.8M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| AB Autoimmunity BioSolutionsCompany profile Genetically guided therapies targeting elevated soluble IL7 receptor levels in autoimmune disease. Genetically guided therapies targeting elevated soluble IL7 receptor levels in autoimmune disease. | $1M | Seed extensionSeed | Healthtech, Biotech | United States | Investors | |
| B BranchLabCompany profile Builds AI platform helping pharma companies identify, activate and optimize patient and HCP audiences Builds AI platform helping pharma companies identify, activate and optimize patient and HCP audiences | $26M | Series A | Healthtech | United States | Investors | |
| R RegulateCompany profile Breathwork app delivering personalised science-backed sessions to improve workplace performance and resilience Breathwork app delivering personalised science-backed sessions to improve workplace performance and resilience | €1.4M | Seed | Healthtech | Germany | Investors | |
| F ForusCompany profile Connects healthcare providers, pharmacies, payers and biopharma through AI-assisted treatment-access workflows. Connects healthcare providers, pharmacies, payers and biopharma through AI-assisted treatment-access workflows. | $160M | Series A | Healthtech | United States | Investors | |
| KH Knit HealthCompany profile Builds clinical behavior AI trained on real-world clinician decision patterns to optimize health system operations Builds clinical behavior AI trained on real-world clinician decision patterns to optimize health system operations | $11.6M | Seed | Healthtech | United States | Investors | |
| TB Tolemy BioCompany profile Develops AI-enabled platform for cell biology research to help biopharma teams interpret and optimise experimental workflows Develops AI-enabled platform for cell biology research to help biopharma teams interpret and optimise experimental workflows | €1.4M | Pre-SeedPre-seed | Healthtech, Biotech | United Kingdom | Investors | |
| D DittoCompany profile AI-powered app that records medical consultations and delivers plain-language summaries for patients AI-powered app that records medical consultations and delivers plain-language summaries for patients | €7.6M | Series A | Healthtech | Netherlands | Investors | |
| IL Isomorphic LabsCompany profile Builds an AI-first drug design engine to accelerate discovery and development across multiple therapeutic areas Builds an AI-first drug design engine to accelerate discovery and development across multiple therapeutic areas | $2.1B | Series B | Healthtech, Biotech | United Kingdom | Investors | |
| B BasataCompany profile Deploys AI agents to automate healthcare admin workflows including referrals, intake, and scheduling Deploys AI agents to automate healthcare admin workflows including referrals, intake, and scheduling | $21M | Series A | Healthtech | United States | Investors | |
| P ParcelBioCompany profile Develops potent and durable mRNA medicines using the APEXm platform for autoimmune and oncology Develops potent and durable mRNA medicines using the APEXm platform for autoimmune and oncology | $13M | Seed | Healthtech, Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →